Targeting the latent reservoir for HIV-1

S Sengupta, RF Siliciano - Immunity, 2018 - cell.com
Antiretroviral therapy can effectively block HIV-1 replication and prevent or reverse
immunodeficiency in HIV-1-infected individuals. However, viral replication resumes within …

Point of care testing for infectious diseases

H Chen, K Liu, Z Li, P Wang - Clinica chimica acta, 2019 - Elsevier
Infectious diseases are caused by pathogenic microorganisms and can be transmitted
between individuals and populations thus threatening the general public health and …

Monocyte-derived macrophages contain persistent latent HIV reservoirs

RT Veenhuis, CM Abreu, PAG Costa, EA Ferreira… - Nature …, 2023 - nature.com
The development of persistent cellular reservoirs of latent human immunodeficiency virus
(HIV) is a critical obstacle to viral eradication since viral rebound takes place once anti …

SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape

S Cele, F Karim, G Lustig, JE San, T Hermanus… - Cell host & …, 2022 - cell.com
Characterizing SARS-CoV-2 evolution in specific geographies may help predict properties
of the variants that come from these regions. We mapped neutralization of a SARS-CoV-2 …

A quantitative approach for measuring the reservoir of latent HIV-1 proviruses

KM Bruner, Z Wang, FR Simonetti, AM Bender… - Nature, 2019 - nature.com
A stable latent reservoir for HIV-1 in resting CD4+ T cells is the principal barrier to a cure,–.
Curative strategies that target the reservoir are being tested, and require accurate, scalable …

Proliferation of latently infected CD4+ T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics

NN Hosmane, KJ Kwon, KM Bruner… - Journal of Experimental …, 2017 - rupress.org
A latent reservoir for HIV-1 in resting CD4+ T lymphocytes precludes cure. Mechanisms
underlying reservoir stability are unclear. Recent studies suggest an unexpected degree of …

Specific HIV integration sites are linked to clonal expansion and persistence of infected cells

F Maldarelli, X Wu, L Su, FR Simonetti, W Shao, S Hill… - Science, 2014 - science.org
The persistence of HIV-infected cells in individuals on suppressive combination antiretroviral
therapy (cART) presents a major barrier for curing HIV infections. HIV integrates its DNA into …

Pathophysiology of CD4+ T-cell depletion in HIV-1 and HIV-2 infections

KK Vidya Vijayan, KP Karthigeyan, SP Tripathi… - Frontiers in …, 2017 - frontiersin.org
The hall mark of human immunodeficiency virus (HIV) infection is a gradual loss of CD4+ T-
cells and imbalance in CD4+ T-cell homeostasis, with progressive impairment of immunity …

Origins of HIV and the AIDS pandemic

PM Sharp, BH Hahn - Cold Spring …, 2011 - perspectivesinmedicine.cshlp.org
Acquired immunodeficiency syndrome (AIDS) of humans is caused by two lentiviruses,
human immunodeficiency viruses types 1 and 2 (HIV-1 and HIV-2). Here, we describe the …

Potency and timing of antiviral therapy as determinants of duration of SARS-CoV-2 shedding and intensity of inflammatory response

A Goyal, EF Cardozo-Ojeda, JT Schiffer - Science advances, 2020 - science.org
To affect the COVID-19 pandemic, lifesaving antiviral therapies must be identified. The
number of clinical trials that can be performed is limited. We developed mathematical …